Genomic impact of cigarette smoke, with application to three smoking-related diseases

Critical Reviews in Toxicology

Volumn 42, Issue 10, 2012, Pages 877-889

  Talikka, M ^a   Sierro, N ^a   Ivanov, N V ^a   Chaudhary, N ^a   Peck, M J ^a   Hoeng, J ^a   Coggins, C R E ^b   Peitsch, M C ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Carson Watts Consulting   (United States)

Author keywords

Chromatin; DNA methylation; Epigenomics; Genomic; Histone modifications; Mutations

Indexed keywords

CARCINOGEN; CIGARETTE SMOKE; DNA; MUTAGENIC AGENT;

CARDIOVASCULAR DISEASE; CHROMATIN; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA METHYLATION; EPIGENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; NONHUMAN; REVIEW; SMOKING;

ANIMALS; CARDIOVASCULAR DISEASES; CHROMATIN; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; INHALATION EXPOSURE; LUNG NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; SMOKING; TOBACCO;

EID: 84867524010     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2012.725244     Document Type: Review

References (130)

1. Adenuga D, Rahman I. (2010). Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes. Arch Biochem Biophys 498:62-73
2. Adenuga D, Yao H, March TH, Seagrave J, Rahman I. (2009). Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 40:464-473
3. Andreassi MG, Botto N. (2003). DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 13:270-275
4. Anisowicz A, Huang H, Braunschweiger KI, Liu Z, Giese H, Wang H, Mamaev S, Olejnik J, Massion PP, Del Mastro RG. (2008). A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer 8:222
5. Anna L, Holmila R, Kovács K, Gyorffy E, Gyori Z, Segesdi J, Minárovits J, Soltøsz I, Kostic S, Csekeo A, Husgafvel-Pursiainen K, Schoket B. (2009). Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary. Mutagenesis 24:475-480
6. Barlow S, Renwick AG, Kleiner J, Bridges JW, Busk L, Dybing E, Edler L, Eisenbrand G, Fink-Gremmels J, Knaap A, Kroes R, Liem D, Müller DJ, Page S, Rolland V, Schlatter J, Tritscher A, Tueting W, Würtzen G. (2006). Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem Toxicol 44:1636-1650
7. Barnes PJ, Adcock IM, Ito K. (2005). Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25:552-563
8. Barnes PJ. (2006). Reduced histone deacetylase in COPD: clinical implications. Chest 129:151-155
9. Barnes PJ. (2009). Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:693-696
10. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. (2007). High-resolution profiling of histone methylations in the human genome. Cell 129:823-837
11. Baryshnikova E, Destro A, Infante MV, Cavuto S, Cariboni U, Alloisio M, Ceresoli GL, Lutman R, Brambilla G, Chiesa G, Ravasi G, Roncalli M. (2008). Molecular alterations in spontaneous sputum of cancerfree heavy smokers: results from a large screening program. Clin Cancer Res 14:1913-1919
12. Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, Wang S, Levy S, Massion PP, Lenburg M, Spira A. (2011). Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res (Phila) 4:803-817
13. Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque MO, Sidransky D. (2011). An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 17:4494-4503
14. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG. (1998). Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95:11891-11896
15. Belinsky SA. (2005). Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 26:1481-1487
16. Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD, Stidley CA, Picchi MA. (2005). Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 11:6505-6511
17. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. (2006). Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 66:3338-3344
18. Bhutani M, Pathak AK, Fan YH, Liu DD, Lee JJ, Tang H, Kurie JM, Morice RC, Kim ES, Hong WK, Mao L. (2008). Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila) 1:39-44
19. Bock C, Tomazou EM, Brinkman AB, Müller F, Simmer F, Gu H, Jäger N, Gnirke A, Stunnenberg HG, Meissner A. (2010). Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 28:1106-1114
20. Broët P, Dalmasso C, Tan EH, Alifano M, Zhang S, Wu J, Lee MH, Røgnard JF, Lim D, Koong HN, Agasthian T, Miller LD, Lim E, Camilleri-Broët S, Tan P. (2011). Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res 17:3542-3550
21. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W. (1995). Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11:210-212
22. Chen ZH, Kim HP, Sciurba FC, Lee SJ, Feghali-Bostwick C, Stolz DB, Dhir R, Landreneau RJ, Schuchert MJ, Yousem SA, Nakahira K, Pilewski JM, Lee JS, Zhang Y, Ryter SW, Choi AM. (2008). Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 3:e3316
23. Chi P, Allis CD, Wang GG. (2010). Covalent histone modifications- miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10:457-469
24. Chung JH, Lee HJ, Kim BH, Cho NY, Kang GH. (2011). DNA methylation profile during multistage progression of pulmonary adenocarcinomas. Virchows Arch 459:201-211
25. Coggins CR. (2010). A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice. Inhal Toxicol 22:974-983
26. Dacic S, Shuai Y, Yousem S, Ohori P, Nikiforova M. (2010). Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas. Mod Pathol 23:159-168
27. Damiani LA, Yingling CM, Leng S, Romo PE, Nakamura J, Belinsky SA. (2008). Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells. Cancer Res 68:9005-9014
28. DeMarini DM, Gudi R, Szkudlinska A, Rao M, Recio L, Kehl M, Kirby PE, Polzin G, Richter PA. (2008). Genotoxicity of 10 cigarette smoke condensates in four test systems: comparisons between assays and condensates. Mutat Res 650:15-29
29. Denissenko MF, Chen JX, Tang MS, Pfeifer GP. (1997). Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci USA 94:3893-3898
30. Denissenko MF, Pao A, Tang M, Pfeifer GP
31. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455:1069-1075
32. Dolinoy DC, Jirtle RL. (2008). Environmental epigenomics in human health and disease. Environ Mol Mutagen 49:4-8
33. Dunn BK. (2003). Hypomethylation: one side of a larger picture. Ann N Y Acad Sci 983:28-42
34. Edwards SW, Preston RJ. (2008). Systems biology and mode of action based risk assessment. Toxicol Sci 106:312-318
35. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514
36. Esteller M. (2007). Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 16 Spec No 1:R50-R59
37. Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H. (2008). DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 17:645-654
38. Fish JE, Yan MS, Matouk CC, St Bernard R, Ho JJ, Ho JJ Jr, Gavryushova A, Srivastava D, Marsden PA. (2010). Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J Biol Chem 285:810-826
39. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM, Miller YE. (1997). Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 100:2133-2137
40. Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C. (2001). Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). J Pathol 193:55-65
41. Gautschi O, Ratschiller D, Gugger M, Betticher DC, Heighway J. (2007). Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55:1-14
42. Gazdar AF, Minna JD. (2009). Multifocal lung cancers-clonality vs field cancerization and does it matter? J Natl Cancer Inst 101:541-543
43. Gebel S, Gerstmayer B, Bosio A, Haussmann HJ, Van Miert E, Müller T. (2004). Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke. Carcinogenesis 25:169-178
44. Gebel S, Gerstmayer B, Kuhl P, Borlak J, Meurrens K, Müller T. (2006). The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. Toxicol Sci 93:422-431
45. Guo X, Verkler TL, Chen Y, Richter PA, Polzin GM, Moore MM, Mei N. (2011). Mutagenicity of 11 cigarette smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis 26:273-281
46. Haberland M, Johnson A, Mokalled MH, Montgomery RL, Olson EN. (2009). Genetic dissection of histone deacetylase requirement in tumor cells. Proc Natl Acad Sci USA 106:7751-7755
47. Hammons G, Lyn-Cook B. (2011). Epigenetics in tobacco smoke exposure. Curr Top Toxicol 7:63-77
48. Hang B. (2010). Formation and repair of tobacco carcinogen-derived bulky DNA adducts. J Nucleic Acids 2010:709521
49. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O'Geen H, Lister R, Pelizzola M, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, Ecker JR, Li W, Farnham PJ, Waterland RA, Meissner A, Marra MA, Hirst M, Milosavljevic A, Costello JF. (2010). Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 28:1097-1105
50. Hartung T. (2009). A toxicology for the 21st century-mapping the road ahead. Toxicol Sci 109:18-23
51. He X, Chang S, Zhang J, Zhao Q, Xiang H, Kusonmano K, Yang L, Sun ZS, Yang H, Wang J. (2008). MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res 36:D836-D841
52. Herbst RS, Heymach JV, Lippman SM. (2008). Lung cancer. N Engl J Med 359:1367-1380
53. Hoeng J, Deehan R, Pratt D, Martin F, Sewer A, Thomson TM, Drubin DA, Waters CA, de Graaf D, Peitsch MC. (2012). A networkbased approach to quantifying the impact of biologically active substances. Drug Discov Today 17:413-418
54. Hou L, Zhang X, Wang D, Baccarelli A. (2012). Environmental chemical exposures and human epigenetics. Int J Epidemiol 41:79-105
55. Huang YT, Lin X, Liu Y, Chirieac LR, McGovern R, Wain J, Heist R, Skaug V, Zienolddiny S, Haugen A, Su L, Fox EA, Wong KK, Christiani DC. (2011). Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer. Proc Natl Acad Sci USA 108:16345-16350
56. Huss M. (2010). Introduction into the analysis of high- throughputsequencing based epigenome data. Brief Bioinformatics 11:512-523
57. Ito K, Barnes PJ. (2009). COPD as a disease of accelerated lung aging. Chest 135:173-180
58. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. (2005). Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352:1967-1976
59. Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K. (2003). Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int J Cancer 106:913-918
60. Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG. (2009). Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol Biomarkers Prev 18:3263-3304
61. Kerr KM, Galler JS, Hagen JA, Laird PW, Laird-Offringa IA. (2007). The role of DNA methylation in the development and progression of lung adenocarcinoma. Dis Markers 23:5-30
62. Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH. (2004). Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 22:2363-2370
63. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. (2010). DNA methylation as a biomarker for cardiovascular disease risk. PLoS ONE 5:e9692
64. Lamy A, Sesboüø R, Bourguignon J, Dautrøaux B, Møtayer J, Frøbourg T, Thiberville L. (2002). Aberrant methylation of the CDKN2a/ p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int J Cancer 100:189-193
65. Lantuøjoul S, Salameire D, Salon C, Brambilla E. (2009). Pulmonary preneoplasia-sequential molecular carcinogenetic events. Histopathology 54:43-54
66. Launay JM, Del Pino M, Chironi G, Callebert J, Peoc'h K, Møgnien JL, Mallet J, Simon A, Rendu F. (2009). Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS ONE 4:e7959
67. Lee YJ, Shim HS, Kang YA, Hong SJ, Kim HK, Kim H, Kim SK, Choi SH, Kim JH, Cho BC. (2010). Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer. J Cancer Res Clin Oncol 136:1937-1944
68. Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, Zheng H, Yu J, Wu H, Sun J, Zhang H, Chen Q, Luo R, Chen M, He Y, Jin X, Zhang Q, Yu C, Zhou G, Sun J, Huang Y, Zheng H, Cao H, Zhou X, Guo S, Hu X, Li X, Kristiansen K, Bolund L, Xu J, Wang W, Yang H, Wang J, Li R, Beck S, Wang J, Zhang X. (2010). The DNA methylome of human peripheral blood mononuclear cells. PLoS.Biol. 8: e1000533
69. Licchesi JD, Westra WH, Hooker CM, Herman JG. (2008). Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res 14:2570-2578
70. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, Lee CF, Wang YC. (2010). The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 120:521-532
71. Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y, Hussain M, Xi S, Rao M, Meltzer PA, Schrump DS. (2010). Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 29:3650-3664
72. Liu H, Zhou Y, Boggs SE, Belinsky SA, Liu J. (2007). Cigarette smoke induces demethylation of prometastatic oncogene synucleingamma in lung cancer cells by downregulation of DNMT3B. Oncogene 26:5900-5910
73. Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, Villar-Garea A, Ballestar E, Esteller M, Zaina S. (2004). DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 279:29147-29154
74. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN, Hong WK. (1997). Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 89:857-862
75. Martin F, Thomson TM, Sewer A, Drubin DA, Mathis C, Weisensee D, Pratt D, Hoeng J, Peitsch MC. (2012). Assessment of network perturbation amplitude by applying high-throughput data to causal biological networks. BMC Syst Biol 6:54
76. Marwick JA, Kirkham PA, Stevenson CS, Danahay H, Giddings J, Butler K, Donaldson K, Macnee W, Rahman I. (2004). Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 31:633-642
77. Mass MJ, Wang L. (1997). Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 386:263-277
78. Mendrick DL. (2008). Toxicogenomics and classic toxicology: how to improve prediction and mechanistic understanding of human toxicity. Methods Mol Biol 460:1-22
79. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. (1995). 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers. Nat Med 1:686-692
80. Monick MM, Beach SR, Plume J, Sears R, Gerrard M, Brody GH, Philibert RA. (2012). Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet 159B:141-151
81. Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT. (1998). Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 58:1804-1807
82. Niedringhaus TP, Milanova D, Kerby MB, Snyder MP, Barron AE. (2011). Landscape of next-generation sequencing technologies. Anal Chem 83:4327-4341
83. Nowell PC. (1976). The clonal evolution of tumor cell populations. Science 194:23-28
84. OECD. (1997). Guideline for the Testing OF Chemicals. In Vitro Mammalian Cell Gene Mutation Test. Available at: http://www. oecd-ilibrary.org/docserver/ download/fulltext/9747601e.pdf?exp ires=1332790058id=idaccname= freeContentchecksum=01D7 55899A5653A11A1D2211DD51662D.
85. Ongenaert M. (2010). Epigenetic databases and computational methodologies in the analysis of epigenetic datasets. Adv. Genet. 71: 259-295
86. Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, Grandis JR, Gaither Davis A, Bigbee WL, Rom W, Sidransky D. (2010). Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin Cancer Res 16:3463-3472
87. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. (2000). Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954-5958
88. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schöfer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T. (2001). Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107:323-337
89. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. (2002). Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435-7451
90. Pfeifer GP, Hainaut P. (2011). Next-generation sequencing: emerging lessons on the origins of human cancer. Curr Opin Oncol 23:62-68
91. Phillips JM, Goodman JI. (2009). Inhalation of cigarette smoke induces regions of altered DNA methylation (RAMs) in SENCAR mouse lung. Toxicology 260:7-15
92. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordoñez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ. (2010). A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184-190
93. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, Belinsky SA. (2004). Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 64:3844-3848
94. Qiu W, Baccarelli A, Carey VJ, Boutaoui N, Bacherman H, Klanderman B, Rennard S, Agusti A, Anderson W, Lomas DA, DeMeo DL. (2012). Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 185:373-381
95. Rahman I. (2002). Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 64:935-942
96. Rahman I, Gilmour PS, Jimenez LA, MacNee W. (2002). Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/ AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 234-235:239-248
97. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. (2008). SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:861-870
98. Rauch T, Li H, Wu X, Pfeifer GP. (2006). MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res 66:7939-7947
99. Rivera C, Rivera S, Loriot Y, Vozenin MC, Deutsch E. (2011). Lung cancer stem cell: new insights on experimental models and preclinical data. J Oncol 2011:549181
100. Rusin MR, Okamoto A, Chorazy M, Czyzewski K, Harasim J, Spillare EA, Hagiwara K, Hussain SP, Xiong Y, Demetrick DJ, Harris CC. (1996). Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Int J Cancer 65:734-739
101. Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S. (2005). Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11:2466-2470
102. Ryberg D, Kure E, Lystad S, Skaug V, Stangeland L, Mercy I, Børresen AL, Haugen A. (1994). p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res 54:1551-1555
103. Sandoval J, Esteller M. (2012). Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22:50-55
104. Schär P, Fritsch O. (2011). DNA repair and the control of DNA methylation. Prog Drug Res 67:51-68
105. Schleef RR. (2006) Animal Models for Three Cigarette-Smoke-Induced Diseases. Boca Raton: CRC Press, Taylor & Francis.
106. Selamat SA, Galler JS, Joshi AD, Fyfe MN, Campan M, Siegmund KD, Kerr KM, Laird-Offringa IA. (2011). DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. PLoS ONE 6:e21443
107. Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD. (2006). A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 3:e486
108. Shan B, Yao TP, Nguyen HT, Zhuo Y, Levy DR, Klingsberg RC, Tao H, Palmer ML, Holder KN, Lasky JA. (2008). Requirement of HDAC6 for transforming growth factor-beta1-induced epithelialmesenchymal transition. J Biol Chem 283:21065-21073
109. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, Karthikeyan G, Ramakrishnan L, Brahmachari V, Sengupta S. (2008). Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 27:357-365
110. Spira A, Schembri F, Beane J, Shah V, Liu G, Brody JS. (2004). Impact of cigarette smoke on the normal airway transcriptome. Chest 125:115S.
111. Steiling K, Ryan J, Brody JS, Spira A. (2008). The field of tissue injury in the lung and airway. Cancer Prev Res (Phila) 1:396-403
112. Stein RA. (2012). Epigenetics and environmental exposures. J Epidemiol Community Health 66:8-13
113. Subramanian J, Govindan R. (2010). Lung cancer in 'Never-smokers': a unique entity. Oncology (Williston Park, NY) 24:29-35
114. Sun S, Schiller JH, Gazdar AF. (2007). Lung cancer in never smokers-a different disease. Nat Rev Cancer 7:778-790
115. Sundar IK, Mullapudi N, Yao H, Spivack SD, Rahman I. (2011). Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics. Curr Opin Pulm Med 17:279-285
116. Szulakowski P, Crowther AJ, Jimønez LA, Donaldson K, Mayer R, Leonard TB, MacNee W, Drost EM. (2006). The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174:41-50
117. U.S. Department of Health and Human Services. (2010). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General., Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA.
118. U.S. Department of Health and Human Services. (2011). Harmful and potentially harmful constituents in tobacco products and tobacco smoke; request for comments., Food and Drug Administration, Federal Register, Vol. 76 Washington, DC: Docket No. FDA-2011-N-0271
119. Van Eeden S, Leipsic J, Paul Man SF, Sin DD. (2012). The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 186:11-16
120. Wierda RJ, Geutskens SB, Jukema JW, Quax PH, van den Elsen PJ. (2010). Epigenetics in atherosclerosis and inflammation. J Cell Mol Med 14:1225-1240
121. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD, Gazdar AF. (1997). Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 89:1366-1373
122. Wynder EL. (1980). Some concepts of the less harmful cigarette, in A safe cigarette? Banbury Report 3 Cold Spring Harbor Laboratory.
123. Yanagawa N, Tamura G, Oizumi H, Endoh M, Sadahiro M, Motoyama T. (2011). Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status. Anticancer Res 31:1211-1214
124. Yang IA, Relan V, Wright CM, Davidson MR, Sriram KB, Savarimuthu Francis SM, Clarke BE, Duhig EE, Bowman RV, Fong KM. (2011). Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 15:439-456
125. Yang SR, Valvo S, Yao H, Kode A, Rajendrasozhan S, Edirisinghe I, Caito S, Adenuga D, Henry R, Fromm G, Maggirwar S, Li JD, Bulger M, Rahman I. (2008). IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am J Respir Cell Mol Biol 38:689-698
126. Zabarovsky ER, Lerman MI, Minna JD. (2002). Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21:6915-6935
127. Zhao Z, Tavoosidana G, Sjölinder M, Göndör A, Mariano P, Wang S, Kanduri C, Lezcano M, Sandhu KS, Singh U, Pant V, Tiwari V, Kurukuti S, Ohlsson R. (2006). Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intraand interchromosomal interactions. Nat Genet 38:1341-1347
128. Zhou B, Margariti A, Zeng L, Xu Q. (2011). Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc Res 90:413-420
129. Zochbauer-Muller S, Minna JD, Gazdar AF. (2002). Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist 7:451-457
130. Zöchbauer-Müller S, Lam S, Toyooka S, Virmani AK, Toyooka KO, Seidl S, Minna JD, Gazdar AF. (2003). Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 107:612-616.